secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001437749-25-031278
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva regains Nasdaq MVLS compliance; still faces bid price delisting risk by Nov 10
--------------------------------------------------------------------------------

- Received Nasdaq letter on Oct 14 confirming compliance with $35M minimum market value of listed securities requirement; matter closed.
- Remains non-compliant with $1.00 minimum bid price rule; initial cure period ends November 10, 2025.
- May consider reverse stock split to regain bid price compliance; no assurance of success.
- Previous MVLS non-compliance resolved after 10 consecutive business days above $35M (Sept 30 to Oct 13).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925031278/0001437749-25-031278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925031278/rvph20251014_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer